Moolec Science SA

MLEC Healthcare Biotechnology

Moolec Science SA’s revenue for fiscal 2025 (year ended June 2025) was $333.6 million, up 5,830.7% from fiscal 2024.

Revenue
+948.4%
EPS
−20.0%
Free cash flow
+4.48%

Quarter to December 2025, against a year earlier

0.85 0.00 0.00%
Market cap
$620.0K
P/E
0.0×
Fwd P/E
−2.5×
Dividend yield
—
F-score
4/9
Altman Z
−1.92
Beneish M
89.08
Dividend safety
0/100
Dec '25 Dec '24 Sep '24 Jun '24 Older periods
ROE
0.00% (174.68%) (104.72%) (5.62%)

+8 more TTM periods

ROA
0.00% (31.42%) (27.74%) (1.50%)
ROIC
0.00% 52.66% 50.68% 1.90%
Return on Tangible Assets
0.00% (190.36%) (151.76%) (8.56%)
Average Days of Receivables
0.00 127.61 108.79 15,853.22
Free Cash Flow per Share
0.00 69.80 72.73 57.99
Free Cash Flow
18.34 18.14 18.76 14.70
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026